Large-scale meta-analysis of infection risk with JAK-STAT inhibitors in 29,000 patients - PubMed
4 hours ago
- #JAK-STAT inhibitors
- #meta-analysis
- #infection risk
- JAK-STAT inhibitors are linked to increased risks of influenza, bronchitis, and herpes zoster in skin-related immune-mediated inflammatory diseases.
- Patients with atopic dermatitis show particularly higher risks for influenza and herpes zoster.
- No significant increase in serious, fungal, or opportunistic infections was found.
- Topical JAK-STAT inhibitors have a safety profile similar to vehicle controls.
- Vaccination and preventive measures are recommended for high-risk atopic dermatitis patients.